Currently untreated adult women , ages @ to @years , with a primary psychiatric diagnosis of PTSD of at least @months ' duration , are being enrolled in a parallel-group , double-blind , placebo-controlled , randomized clinical trial evaluating the efficacy and safety of GSK@ , a novel CRHR@ receptor antagonist .